Recommendations for Cervical Cancer Prevention in Latin America and the Caribbean

Vaccine

Volumn 26, Issue SUPPL. 11, 2008, Pages

  Muñoz, Nubia ^a,b   Franco, Eduardo L ^c   Herrero, Rolando ^d   Andrus, Jon Kim ^e   de Quadros, Ciro ^f   Goldie, Sue J ^g   Bosch, F Xavier ^b  

^a Instituto Nacional de Cancerología   (Colombia)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c MCGILL UNIVERSITY   (Canada)

^d PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^e PAN AMERICAN HEALTH ORGANIZATION   (United States)

^f Albert B Sabin Vaccine Institute   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Caribbean; Cervical cancer; Cervical cancer screening; HPV; HPV vaccines; Latin America; Policy

Indexed keywords

PLACEBO; VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CARIBBEAN ISLANDS; CHILD; CHILE; CLINICAL PRACTICE; COLOMBIA; CONDYLOMA ACUMINATUM; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENITAL TRACT CANCER; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MEXICO; NONHUMAN; PAPANICOLAOU TEST; PERU; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPEATED DRUG DOSE; SOUTH AND CENTRAL AMERICA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH;

CARIBBEAN REGION; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; LATIN AMERICA; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 50849112079     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.05.062     Document Type: Article

References (23)

1. Bosch F.X., Muñoz N., Herrero R., Bruni L., Garland S.M., Cuzick J., et al. Prevention of Cervical Cancer in the Latin America and Caribbean Region: Progress and Challenges on HPV Vaccination and Screening. Vaccine 26 Suppl 11 (2008)
2. de Sanjose S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7 7 (2007) 453-459
3. Smith J.S., Lindsay L., Hoots B., Keys J., Franceschi S., Winer R., et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121 3 (2007) 621-632
4. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A., de Sanjose S., Bruni L., et al. Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia. Vaccine 26 Suppl 10 (2008) K1-K15
5. Almonte M., Albero G., Molano M., Carcamo C., García P.J., and Pérez G. Risk factors for Human Papillomavirus Exposure and Co-Factors for Cervical Cancer in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L16-L36
6. Parkin D.M., Almonte M., Bruni L., Clifford G., Curado M.P., and Piñeros M. Burden and Trends of Type-Specific Human Papillomavirus Infections and Related Diseases in the Latin America and Caribbean Region. Vaccine 26 Suppl 11 (2008) L1-L15
7. Ferlay J., Bray F., Pisani P., and Parkin D.M. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0 (2004), IARC Press, Lyon
8. Murillo R., Almonte M., Pereira A., Ferrer E., Gamboa O.A., Jerónimo J., et al. Cervical Cancer Screening Programs in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L37-L48
9. Giuliano A., Tortolero-Luna G., Ferrer E., Burchell A.N., de Sanjose S., Kruger Kjaer S., et al. Epidemiology of Human Papillomavirus in Men, Cancers other than Cervical and Benign Conditions. Vaccine 26 Suppl 10 (2008) K16-K28
10. Garcia P.J., Chavez S., Feringa B., Chiappe M., Li W., Jansen K.U., et al. Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru. Bull World Health Organ 82 7 (2004 Jul) 483-492
11. Schiller J., Castellsagué X., Villa L., and Hildesheim A. An Update of Prophylactic Human Papillomavirus L1 Virus-Like Particle Vaccine Clinical Trial Results. Vaccine 26 Suppl 10 (2008) K52-K60
12. Franco E.L., Tsu V., Herrero R., Lazcano-Ponce E., Hildesheim A., Muñoz N., et al. Integration of Human Papillomavirus Vaccination and Cervical Cancer Screening in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L88-L95
13. Shefer A., Markowitz L., Deeks S.H., Tam T.H., Irwin K., Garland S., et al. Early Experience with Human Papillomavirus Vaccine Introduction in the United States, Canada, and Australia. Vaccine 26 Suppl 10 (2008) L68-L75
14. Andrus J.K., Sherris J., Fitzsimmons J.W., Kane M.A., and Aguado T. Introduction of Human Papillomavirus Vaccines into Developing Countries - International Strategies for Funding and Procurement. Vaccine 26 Suppl 10 (2008) L87-L92
15. Andrus J.K., Lewis M.J., Goldie S.J., García P.J., Winkler J.L., Ruiz-Matus C., et al. Human Papillomavirus Vaccine Policy and Delivery in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L80-L87
16. Winkler J.L., Wittet S., Bartolini R., Creed-Kanashiro H.M., Lazcano-Ponce E., Lewis-Bell K., et al. Determinants of Human Papillomavirus Vaccine Acceptability in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L73-L79
17. Herrero R., Ferreccio C., Salmerón J., Almonte M., Sánchez G., Lazcano-Ponce E., et al. New Approaches to Cervical Cancer Screening in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L49-L58
18. Sankaranarayanan R., Esmy P.O., Rajkumar R., Muwonge R., Swaminathan R., Shanthakumari S., et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet 370 9585 (2007) 398-406
19. Goldie S.J., Diaz M., Constenla D., Alvis N., Andrus J.K., and Kim S.Y. Mathematical Models of Cervical Cancer Prevention in Latin America and the Caribbean. Vaccine 26 Suppl 11 (2008) L59-L72
20. World Health Organization (WHO). Macroeconomics and health: investing in health for economic development: report of the commission on macroeconomics and health (2001), World Health Organization, Geneva
21. World Health Organization (WHO). Statistical Information System: CHOICE (CHOosing Interventions that are Cost Effective). Available at: http://www.who.int/choice/en/ (last accessed: April 2008).
22. Gravitt P., Coutlée F., Iftner T., Sellors J., Quint W., and Wheeler C.M. New Technologies in Cervical Cancer Screening. Vaccine 26 Suppl 10 (2008) K42-K51
23. Schiffman M., and Castle P.E. The promise of global cervical-cancer prevention. N Engl J Med 353 20 (2005) 2101-2104